Thiamine dose response in human milk with supplementation among lactating women in Cambodia: Study protocol for a double-blind, four-parallel arm randomised controlled trial

Kyly C. Whitfield, Hou Kroeun, Tim Green, Frank T. Wieringa, Mam Borath, Prak Sophonneary, Jeffrey R. Measelle, Dare Baldwin, Lisa N. Yelland, Shalem Leemaqz, Kathleen Chan, Jelisa Gallant

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi. Thiamine fortification of salt is a potentially low-cost, passive means of combating thiamine deficiency; however, both the dose of thiamine required to optimise milk thiamine concentrations as well as usual salt intake of lactating women are unknown. Methods and analysis: In this community-based randomised controlled trial, 320 lactating women from Kampong Thom, Cambodia will be randomised to one of four groups to consume one capsule daily containing 0, 1.2, 2.4 or 10 mg thiamine as thiamine hydrochloride, between 2 and 24 weeks postnatal. The primary objective is to estimate the dose where additional maternal intake of thiamine no longer meaningfully increases infant thiamine diphosphate concentrations 24 weeks postnatally. At 2, 12 and 24 weeks, we will collect sociodemographic, nutrition and health information, a battery of cognitive assessments, maternal (2 and 24 weeks) and infant (24 weeks only) venous blood samples (biomarkers: ThDP and transketolase activity) and human milk samples (also at 4 weeks; biomarker: milk thiamine concentrations). All participants and their families will consume study-provided salt ad libitum throughout the trial, and we will measure salt disappearance each fortnight. Repeat weighed salt intakes and urinary sodium concentrations will be measured among a subset of 100 participants. Parameters of Emax dose-response curves will be estimated using non-linear least squares models with both 'intention to treat' and a secondary 'per-protocol' (capsule compliance ≥80%) analyses. Ethics and dissemination: Ethical approval was obtained in Cambodia (National Ethics Committee for Health Research 112/250NECHR), Canada (Mount Saint Vincent University Research Ethics Board 2017-141) and the USA (University of Oregon Institutional Review Board 07052018.008). Results: will be shared with participants' communities, as well as relevant government and scientific stakeholders via presentations, academic manuscripts and consultations.

Original languageEnglish
Article numbere029255
Number of pages9
JournalBMJ Open
Volume9
Issue number7
DOIs
Publication statusPublished - Jul 2019
Externally publishedYes

Bibliographical note

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Keywords

  • dose response
  • fortification
  • human milk
  • infant cognitive development
  • salt
  • thiamine (vitamin B1)

Fingerprint Dive into the research topics of 'Thiamine dose response in human milk with supplementation among lactating women in Cambodia: Study protocol for a double-blind, four-parallel arm randomised controlled trial'. Together they form a unique fingerprint.

  • Cite this

    Whitfield, K. C., Kroeun, H., Green, T., Wieringa, F. T., Borath, M., Sophonneary, P., Measelle, J. R., Baldwin, D., Yelland, L. N., Leemaqz, S., Chan, K., & Gallant, J. (2019). Thiamine dose response in human milk with supplementation among lactating women in Cambodia: Study protocol for a double-blind, four-parallel arm randomised controlled trial. BMJ Open, 9(7), [e029255]. https://doi.org/10.1136/bmjopen-2019-029255